No Data
No Data
BRISTOL-MYERS SQUIBB CO CELGENE CONTINGENT VAL RIGHTS 12/31/2030 To Go Ex-Dividend On March 7th, 2024 With 0.0199 USD Dividend Per Share
February 24th - $BRISTOL-MYERS SQUIBB CO CELGENE CONTINGENT VAL RIGHTS 12/31/2030(CELG.RT.US)$ is trading ex-dividend on March 7th, 2024. Shareholders of record on March 9th, 2024 will receive 0.0
Regenerative Medicine Market Size to Worth USD 95 Billion by 2032
The regenerative medicine market size surpassed 16.55 billion in 2023 and is growing at a healthy CAGR of 21.4% between 2023 and 2032, as a result of the rising demand for cell and gene therapies.
No Data